在缺血性 mitrale 排泄手术中决定早期死亡率的因素
Batuhan Yazıcı1, Zinar Apaydın2, Mustafa Can Kaplan3
1Department of Cardiovascular Surgery, Hatay Training and Research Hospital, Hatay, Türkiye.
Turk gogus kalp damar cerrahisi dergisi
|June 27, 2025
概括
mitra valve 手术和冠状动脉旁路移植后的早期死亡率与患者的年龄,女性性别和紧急手术有关. 仔细的手术前评估和优先病例的战略等待期可以改善结果.
科学领域:
- 心血管外科心血管外科
- 心脏外科手术的结果
- 中心门疾病的疾病.
背景情况:
- 缺血性额头吐 (IMR) 需要复杂的手术干预.
- 对IMR进行了组合的 mitra 门手术和冠状动脉旁路移植 (CABG).
- 确定这些患者的早期死亡原因对于改善手术结果至关重要.
研究的目的:
- 确定那些因子导致早期死亡的因素,在经历了合并的 mitra 门手术和 CABG IMR 患者.
- 分析手术时间和患者特征对住院死亡率的影响.
主要方法:
- 在2017年1月至2023年1月期间,对411名患者进行了关膜外科手术和CABG联合IMR的回顾性分析.
- 根据住院死亡率对患者进行了分类.
- 进行了统计分析,以确定死亡率的独立风险因素.
主要成果:
- 在医院的死亡率为13.6% (n=56).
- 死亡的独立风险因素包括晚年,女性性别,优先 (紧急) 手术,低射出分数,肌素升高,心外动脉,以及心肺绕道时间延长.
- 在优先病例中,等待期≤9天与明显更高的死亡率有关.
结论:
- 综合性手术前评估对于优化IMR患者的治疗结果至关重要.
- 对于高风险个体,可以考虑采用不那么侵入性的方法.
- 如果血液动力学稳定,优先病例的等待期长达九天,可能会降低死亡率.
相关概念视频
Mitral Regurgitation IV: Nursing Management
92
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
92
Mitral Regurgitation I: Introduction
64
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
64
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
60
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
60
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34
Mitral Stenosis I: Introduction
48
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
48
Mitral Stenosis III: Medical Management
28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28


